Health
mRNA-based COVID-19 vaccination during pregnancy provides passive SARS-CoV-2 immunity to neonates 16 days after first dose – News-Medical.Net
Recently, a group of researchers analyzed 122 pregnant women and their neonates at the time of birth. All the women studied received 1 or both doses of a messenger…
Initial clinical trials for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines excluded pregnant women. Thus, pregnant women’s immune response to vaccination and the transplacental transfer of maternal antibodies to the fetus is not yet studied in detail.
Recently, a group of researchers analyzed 122 pregnant women and their neonates at the time of birth. All the women studied received 1 or both doses of a messenger RNA (mRNA)-based vaccine for COVID-19. Of the 122 women part…
-
General19 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
General22 hours agoAlbanese beats drum on economy as trade clouds gather
-
Noosa News21 hours agoSurgeon partner of former premier to testify over his patient’s death
-
Business19 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher